Layla D. Berry

Array ( [id] => 11421301 [patent_doc_number] => 20170029445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'ASYMMETRIC AUXILIARY GROUP' [patent_app_type] => utility [patent_app_number] => 15/294602 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20035 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17044967 [patent_doc_number] => 11098135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Methylated cyclodextrins and methods for the production thereof [patent_app_type] => utility [patent_app_number] => 15/767958 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7337 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13063069 [patent_doc_number] => 10052304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => Compositions and methods for cancer therapy [patent_app_type] => utility [patent_app_number] => 15/291833 [patent_app_country] => US [patent_app_date] => 2016-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 112 [patent_no_of_words] => 26514 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12118779 [patent_doc_number] => 20180002365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'OLIGOSACCHARIDE-PROTEIN CONJUGATES' [patent_app_type] => utility [patent_app_number] => 15/288486 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 32598 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11677128 [patent_doc_number] => 09675634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Hydroxypropyl beta-cyclodextrin compositions and methods' [patent_app_type] => utility [patent_app_number] => 15/288876 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 63 [patent_no_of_words] => 49066 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11400794 [patent_doc_number] => 20170021332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'ENDOTOXIN ADSORBENT' [patent_app_type] => utility [patent_app_number] => 15/285465 [patent_app_country] => US [patent_app_date] => 2016-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11274 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11663560 [patent_doc_number] => 20170152280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'SCAPHOPETALONE ANALOGS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 15/282468 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5067 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11393985 [patent_doc_number] => 20170014520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/280864 [patent_app_country] => US [patent_app_date] => 2016-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10167 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12904924 [patent_doc_number] => 20180193483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => DRUG FORMULATION BASED ON PARTICULATES COMPRISING POLYSACCHARIDE-VITAMIN CONJUGATE [patent_app_type] => utility [patent_app_number] => 15/745066 [patent_app_country] => US [patent_app_date] => 2016-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15144947 [patent_doc_number] => 20190350951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => COMBINATIONS OF A MITHRAMYCIN ANALOGUE AND ANOTHER CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER [patent_app_type] => utility [patent_app_number] => 15/760850 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13386319 [patent_doc_number] => 20180244701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => Phosphoramidate Compound and Preparation Method and Crystal Thereof [patent_app_type] => utility [patent_app_number] => 15/754318 [patent_app_country] => US [patent_app_date] => 2016-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13371851 [patent_doc_number] => 20180237466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => Preparation Method of Nucleoside Phosphoramidate Prodrugs and Intermediates Thereof [patent_app_type] => utility [patent_app_number] => 15/753734 [patent_app_country] => US [patent_app_date] => 2016-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10808 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13125703 [patent_doc_number] => 10080766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria [patent_app_type] => utility [patent_app_number] => 15/263766 [patent_app_country] => US [patent_app_date] => 2016-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 102 [patent_no_of_words] => 29863 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15263766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11542620 [patent_doc_number] => 20170096445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'PROCESS FOR THE PREPARATION OF MACROLIDE ANTIBACTERIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 15/262277 [patent_app_country] => US [patent_app_date] => 2016-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9701 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13672625 [patent_doc_number] => 20160375046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => METHOD FOR TREATMENT OF DISEASE WITH PURE PORCINE MONOSIALOGANGLIOSIDE GM1 [patent_app_type] => utility [patent_app_number] => 15/258673 [patent_app_country] => US [patent_app_date] => 2016-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12138276 [patent_doc_number] => 20180016359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'SUGAMMADEX PREPARATION AND PURIFICATION METHOD' [patent_app_type] => utility [patent_app_number] => 15/544226 [patent_app_country] => US [patent_app_date] => 2016-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7500 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11310198 [patent_doc_number] => 20160346308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'COMPOSITION AND METHOD OF USE FOR COMBINATIONS OF ANTI-VIRAL PROTEASE, POLYMERASE INHIBITORS AND NATURAL BIOACTIVE COMPOUNDS IN THE TREATMENT OF HEPATITIS C INFECTION' [patent_app_type] => utility [patent_app_number] => 15/234291 [patent_app_country] => US [patent_app_date] => 2016-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21420 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15234291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13013867 [patent_doc_number] => 10030041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => C-terminal Hsp90 inhibitors [patent_app_type] => utility [patent_app_number] => 15/227230 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23249 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13342923 [patent_doc_number] => 20180223001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => NOVEL METHOD FOR THE POLYMERIZATION OF SUGARS [patent_app_type] => utility [patent_app_number] => 15/748482 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15160685 [patent_doc_number] => 10485815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Substituted nucleosides, nucleotides and analogs thereof [patent_app_type] => utility [patent_app_number] => 15/221961 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 82208 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15221961 [rel_patent_id] =>[rel_patent_doc_number] =>)